Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Araceli Salamanca Cuenca"'
Autor:
Lucía Pérez-Lamas, Alejandro Luna, Concepcion Boque, María Alicia Senin, Blanca Xicoy, Pilar Giraldo, Raul Perez Lopez, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Carmen Garcia-Hernandez, Adrian Segura Diaz, Juan Luis Steegmann, Patricia Velez Tenza, Fermin Sanchez-Guijo, Ana Maria Garcia-Noblejas Moya, Juan Antonio Juan Vera Goñi, Melania Moreno Vega, Alberto Alvarez-Larran, Montse Cortes, Manuel Perez Encinas, Luis Serrano, Anna Angona, Ana Rosell, Sunil Lakhwani, Mercedes Colorado, Elena Ramila, Carlos Cervero, Beatriz Cuevas, Lucia Villalon Blanco, Juan Carlos Hernandez Boluda, Antonio Paz Coll, Valle Gómez García de Soria, Maria Jose Fernández, Luis Felipe Casado, Juan Manuel Alonso-Dominguez, Maria Magdalena Anguita Arance, Patricia Carrascosa Mastell, Araceli Salamanca Cuenca, Antonio Jiménez-Velasco, María José Ramírez, Miguel López Esteban, Magdalena Sierra Pacho, Marta Santaliestra, Olga Alda Alvarez, Raquel de Paz, Valentín García Gutiérrez
Publikováno v:
Blood. 140:3925-3928
Autor:
Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque, Blanca Xicoy, Pilar Giraldo, Raúl Pérez López, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Javier López Marín, Adrián Segura Díaz, Valle Gómez, Patricia Vélez Tenza, Magdalena Sierra Pacho, Juan Antonio Vera Goñi, Melania Moreno Vega, Alberto Alvarez-Larrán, Montse Cortés, Manuel Pérez Encinas, Patricia Carrascosa Mastell, Anna Angona, Ana Rosell, Sunil Lakhwani, Mercedes Colorado, Elena Ramila, Carlos Cervero, Beatriz Cuevas, Lucía Villalón Blanco, Raquel de Paz, Antonio Paz Coll, María José Fernández, Luis Felipe Casado, Juan Manuel Alonso-Domínguez, María Magdalena Anguita Arance, Araceli Salamanca Cuenca, Antonio Jiménez-Velasco, Santiago Osorio Prendes, Marta Santaliestra, María José Lis Chulvi, Juan Carlos Hernández-Boluda, Valentín García-Gutiérrez
Publikováno v:
Scientia
Cancers
Volume 15
Issue 4
Pages: 1045
Cancers
Volume 15
Issue 4
Pages: 1045
Simple Summary After the recent irruption of asciminib into the therapeutic arsenal for chronic myeloid leukemia, real-life data remain scarce to determine which patients may benefit most from this drug. Data on the efficacy of the drug in real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d62a6253d555f83c73979b06dacbda
https://hdl.handle.net/11351/9705
https://hdl.handle.net/11351/9705
Autor:
Angeles Escola, Fermín Sánchez-Guijo, Elena Rámila, Elvira Mora Casterá, Juan Carlos Hernandez Boluda, Alejandro Luna, Concepción Boqué, Rocio Fé Bitaube, Valle Gomez, Sunil Lakhwani, Ana García-Noblejas, Melania Moreno Vega, Sara Suarez-Varela, Miguel Sagüés, Valentín García Gutiérrez, Ana Rosell, Luis Serrano, Montse Cortés, Raul Perez Lopez, Juan Luis Steegmann, Ferran Vall-Llovera, Patricia Velez, Antonio Jiménez-Velasco, Carlos Cerveró, Maria Jose Fernández, Mercedes Colorado Araujo, Manuel Mateo Pérez Encinas, Concepción Ruiz Nuño, Antonio Paz Coll, Pilar Giraldo, Natalia de las Heras, Luis Felipe Casado, Araceli Salamanca Cuenca, Lucia Villalon, Beatriz Cuevas, Juan-Manuel Alonso-Domínguez, Carmen Garcia-Hernandez, Lucía Pérez-Lamas, Juan Antonio Juan Vera Goñi, Blanca Xicoy, Patricia Carrascosa Mastell, Alberto Alvarez-Larrán
Publikováno v:
Blood. 138:2563-2563
Introduction: asciminib is a first-in-class STAMP (Specifically Targeting the ABL Myristoyl Pocket) inhibitor that potently inhibits aberrant kinase activity of the BCR-ABL1 oncoprotein via allosteric binding. asciminib has shown high efficacy profil